Network-guided identification and multi-targeting of cell cycle regulatory hubs in obesity-linked colorectal cancer
By shifting from a "one-target, one-drug" model to a systems-level approach, the proposed MTDL and its natural analogs represent promising candidates for experimental validation in the treatment of complex, obesity-associated CRC.